Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings

Shares (Q2 2026)
66,971
Value
$1.72M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of DNLI by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202666,971$1.72M<0.1%−114,446−63.1%ReducedHolders
Q1 2026181,417$3.48M<0.1%−597,731−76.7%ReducedHolders
Q4 2025779,148$12.9M<0.1%+90,924+13.2%AddedHolders
Q3 2025688,224$9.99M<0.1%−560,729−44.9%ReducedHolders
Q2 20251,248,953$17.5M<0.1%+79,270+6.8%AddedHolders
Q1 20251,169,683$15.9M<0.1%+339,772+40.9%AddedHolders
Q4 2024829,911$16.9M<0.1%+52,631+6.8%AddedHolders
Q3 2024777,280$22.6M<0.1%−441,418−36.2%ReducedHolders
Q2 20241,218,698$28.3M<0.1%−146,330−10.7%ReducedHolders
Q1 20241,365,028$28.0M<0.1%+1,296,918+1,904.2%AddedHolders
Q4 202368,110$1.46M<0.1%+6,205+10.0%AddedHolders
Q3 202361,905$1.28M<0.1%+5,802+10.3%AddedHolders
Q2 202356,103$1.66M<0.1%−1,318,222−95.9%ReducedHolders
Q1 20231,374,325$31.7M<0.1%+1,339,712+3,870.5%AddedHolders
Q4 202234,613$962.6K<0.1%−28,924−45.5%ReducedHolders
Q3 202263,537$1.95M<0.1%−242,465−79.2%ReducedHolders
Q2 2022306,002$9.01M<0.1%−445,601−59.3%ReducedHolders
Q1 2022751,603$24.2M<0.1%+265,920+54.8%AddedHolders
Q4 2021485,683$21.7M<0.1%+422,672+670.8%AddedHolders
Q3 202163,011$3.18M<0.1%+63,011NewHolders
Q2 20210$00.0%−240,784−100.0%Sold outHolders
Q1 2021240,784$13.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.